ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryPrattelnSanthera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG Logo
Verified· 4 sources

Santhera Pharmaceuticals (Schweiz) AG

Summary

About the company

Santhera Pharmaceuticals (Schweiz) AG develops and commercializes medicines for patients with rare and other diseases that have high unmet medical needs. The company focuses on developing treatments for neuromuscular disorders, such as Duchenne muscular dystrophy.

AI-generated
Offering
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Products & services

Industry:Pharmaceutical Industry
✓ Offered4
Medicines for rare neuromuscular and pulmonary diseases
Development of treatments for rare diseases, in particular neuromuscular and pulmonary diseases with unmet medical need.
AGAMREE® (vamorolone)
AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy; described on the website with approval status, product information and ordering instructions for pharmacies.
Scientific publications and clinical information
Scientific publications, clinical studies and medical information on AGAMREE® and the development programme with vamorolone.
Career positions
Open positions and career information for employees in an international environment of medical science.
Reviews

Aggregated rating

Aggregated rating
4.7
of 5

Aggregated from 3 reviews across all connected sources

Sources
GGoogle4.73
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

January 8, 2026Media
Aktie von Santhera vollzieht Kurssprung nach Lizenzvereinbarung für Medikament Agamree
cash.ch

Knowledge

No knowledge articles yet

Once Santhera Pharmaceuticals (Schweiz) AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Santhera Pharmaceuticals (Schweiz) AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Santhera Pharmaceuticals (Schweiz) AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Santhera Pharmaceuticals (Schweiz) AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hohenrainstrasse 24
4133 Pratteln

At a glance

Legal form
Corporation
UID
CHE-112.001.828
Founded
2004 · 22 years
Last commercial register change
September 4, 2026
Employees
21 to 50

Similar companies

GP
Gebro Pharma AG
Liestal
AH
Accord Healthcare AG
Bottmingen
CG
Cederberg GmbH
Binningen
NS
Neurocrine Switzerland GmbH
Allschwil
HA
Herbonis Animal Health GmbH
Augst Bl
AG
Allpack Group AG
Reinach Bl
MA
Medius AG
Muttenz
AP
Actelion Pharmaceuticals Ltd
Allschwil